Asset
VARLILUMAB
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01460134 | phase1 | completed | 2011-10-01 | 2015-12-01 | Celldex Therapeutics | A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers |
| NCT02302339 | phase2 | terminated | 2014-11-01 | 2018-06-14 | Celldex Therapeutics | A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma |
FDA applications (0)
This company has no applications containing this asset.